|
|
 Previous Article | Table of Contents | Next Article 
Modulation of Idarubicin-Induced Apoptosis in Human Acute Myeloid Leukemia Blasts by All-Trans Retinoic Acid, 1,25(OH)2 Vitamin D3, and Granulocyte-Macrophage Colony-Stimulating Factor
Nicolas J. Ketley,
Paul D. Allen,
Stephen M. Kelsey, and
Adrian C. Newland
From the Department of Haematology, St Bartholomew's; and the Royal London School of Medicine and Dentistry, London, United Kingdom.
The relationship between differentiation of human myeloid cells and apoptosis remains unclear. Recent studies have shown that terminal differentiation need not necessarily lead to the apoptotic demise of myeloid cells, while other studies have shown that induction of differentiation is associated with increased resistance to apoptosis-inducing agents, such as chemotherapy and  -irradiation. Such results are pertinent to the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome, where differentiating agents and hemopoietic growth factors are being combined with chemotherapy to enhance response and limit toxicity. To elucidate the factors governing apoptosis in human AML blasts, we have studied the cytotoxic effect of idarubicin on HL60, U937 and KG1 cells, after incubation with all-trans retinoic acid (ATRA), 1,25(OH)2 D3, and granulocyte-macrophage colony-stimulating factor (GM-CSF ). We show that prior incubation of human myeloid leukemic cells with ATRA or 1,25(OH)2 D3 induced resistance to idarubicin-induced apoptosis, which was modulated by coincubation with GM-CSF. The altered chemosensitivity of cells depended on the degree of G0/G1 cell-cycle arrest induced by incubation with ATRA, 1,25(OH)2 D3, and GM-CSF and was independent of differentiation status or Bcl-2 oncoprotein expression. These findings suggest that cell-cycle arrest in human leukemic cells can be induced by exogenous agents and may promote drug resistance. Determining the mechanisms by which cell-cycle arrest is induced may permit understanding of the processes by which the cells escape cytotoxic drug-mediated apoptosis.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4578-4587
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Otake, T. K. Sengupta, S. Bandyopadhyay, E. K. Spicer, and D. J. Fernandes
Retinoid-Induced Apoptosis in HL-60 Cells Is Associated with Nucleolin Down-Regulation and Destabilization of Bcl-2 mRNA
Mol. Pharmacol.,
January 1, 2005;
67(1):
319 - 326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Kim, H. Lee, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim
Promoter Methylation of Retinoic Acid Receptor Beta 2 and the Development of Second Primary Lung Cancers in Non-Small-Cell Lung Cancer
J. Clin. Oncol.,
September 1, 2004;
22(17):
3443 - 3450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Moqattash and J. D. Lutton
Leukemia Cells and the Cytokine Network: Therapeutic Prospects
Experimental Biology and Medicine,
February 1, 2004;
229(2):
121 - 137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Vondrácek, M. A. Sheard, P. Krejcí, K. Minksová, J. Hofmanová, and A. Kozubík
Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells
J. Leukoc. Biol.,
May 1, 2001;
69(5):
794 - 802.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
O. Bruserud, B. T. Gjertsen, and T.-s. Huang
Induction of Differentiation and Apoptosis-- A Possible Strategy in the Treatment of Adult Acute Myelogenous Leukemia
Oncologist,
December 1, 2000;
5(6):
454 - 462.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Allouche, R. S. Charrad, A. Bettaieb, C. Greenland, C. Grignon, and F. Smadja-Joffe
Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells
Blood,
August 1, 2000;
96(3):
1187 - 1190.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Bruserud and B. T. Gjertsen
New Strategies for the Treatment of Acute Myelogenous Leukemia: Differentiation Induction--Present Use and Future Possibilities
Stem Cells,
May 1, 2000;
18(3):
157 - 165.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
V. Moreno-Manzano, Y. Ishikawa, J. Lucio-Cazana, and M. Kitamura
Suppression of Apoptosis by All-trans-Retinoic Acid. DUAL INTERVENTION IN THE c-JUN N-TERMINAL KINASE-AP-1 PATHWAY
J. Biol. Chem.,
July 16, 1999;
274(29):
20251 - 20258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Baier, T. Bondeva, R. Klinger, A. Bondev, and R. Wetzker
Retinoic Acid Induces Selective Expression of Phosphoinositide 3-Kinase {{gamma}} in Myelomonocytic U937 Cells
Cell Growth Differ.,
June 1, 1999;
10(6):
447 - 456.
[Abstract]
[Full Text]
|
|
|
| |
